1. Home
  2. IMAX vs VCEL Comparison

IMAX vs VCEL Comparison

Compare IMAX & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imax Corporation

IMAX

Imax Corporation

HOLD

Current Price

$56.13

Market Cap

2.4B

Sector

N/A

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$40.24

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMAX
VCEL
Founded
1967
1989
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.4B
IPO Year
1997
1996

Fundamental Metrics

Financial Performance
Metric
IMAX
VCEL
Price
$56.13
$40.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
5
Target Price
$44.50
★ $57.75
AVG Volume (30 Days)
★ 837.9K
423.3K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
31.25
★ 60.00
EPS
★ 0.35
N/A
Revenue
★ $410,212,000.00
$276,259,000.00
Revenue This Year
$9.79
$19.40
Revenue Next Year
$7.51
$18.24
P/E Ratio
$160.49
★ N/A
Revenue Growth
★ 16.47
16.45
52 Week Low
$30.74
$28.95
52 Week High
$56.68
$49.32

Technical Indicators

Market Signals
Indicator
IMAX
VCEL
Relative Strength Index (RSI) 66.13 49.72
Support Level $34.43 $33.21
Resistance Level N/A $41.12
Average True Range (ATR) 1.81 1.24
MACD 0.22 0.24
Stochastic Oscillator 76.78 87.60

Price Performance

Historical Comparison
IMAX
VCEL

About IMAX Imax Corporation

Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: